Christine Cassiano | Chief Communications Officer |
David Chang | President and Chief Executive Officer |
Rafael Amado | EVP of Research and Development and Chief Medical Officer |
Eric Schmidt | Chief Financial Officer |
Tyler Van Buren | Cowen |
Cory Kasimov | JP Morgan |
Salveen Richter | Goldman Sachs |
John Newman | Canaccord |
Luca Issi | RBC Capital |
Kalpit Patel | B. Riley |
Anand Sankar | Truist |
Raju Prasad | William Blair |
Dane Leone | Raymond James |
Thank you for standing by, and Welcome to Allogene Therapeutics First Quarter 2022 Conference Call [Operator Instructions]. I would now like to turn the call over to Christine Cassiano, Chief Communications Officer. Please go ahead.
Thank you, operator, and welcome to all who have joined this call. After the market closed today, Allogene issued a press release that provides a business update and financial results for the first quarter of 2022.